IQVIA collaborates with NVIDIA to augment healthcare with agentic AI
IQVIA, the company powering smarter healthcare, is collaborating with NVIDIA to launch a series of AI orchestrator agents engineered to manage and accelerate complex pharmaceutical development workflows. Addressing the needs of IQVIA’s thousands of global pharmaceutical, biotech, and medical device customers, this collaboration brings the advantages of agentic AI to drug research and development.
IQVIA’s AI orchestrator agents—which manage groups of sub-agents specializing in different tasks—help expedite the full pharmaceutical lifecycle, including clinical trials, according to the company.
These agents accelerate the often lengthy process of planning and executing clinical trials—which can take as long as years to facilitate. With IQVIA’s AI orchestrator agents—which utilize NVIDIA NIM microservices, part of the NVIDIA AI Enterprise software platform—research teams are afforded the ability to focus more on impactful decision making, streamlining clinical site start-up and eliminating manual, time-consuming tasks.
“From molecule to market, AI promises to be transformative for life sciences and healthcare,” said Avinob Roy, vice president and general manager of product offerings for commercial analytics solutions at IQVIA.
After clinical trials, IQVIA’s AI orchestrator agents can enhance drug commercialization, delivering a robust understanding of how a treatment will reach patients by analyzing patient records, prescriptions, and lab results—all in just a few days instead of weeks, according to the company. Additionally, with the help of the IQVIA field companion orchestrator agent, pharmaceutical sales teams’ workflows are augmented with tailored insights based on physician demographics and digital behavior. This near real-time, data-driven, personalized information helps prepare field teams for each individual meeting, boosting their impact.
“The collective impact of these agents across numerous commercial workflows brings unprecedented precision and operational efficiency to the life sciences, supporting better experiences and outcomes for healthcare professionals and patients,” said Roy.
To learn more about this collaboration, please visit https://www.iqvia.com/.